Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genprex, Inc.GNPX · Entity 8441 | Director | April 14, 2026 | April 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genprex, Inc.
Report date April 14, 2026 · Filed April 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,157 |
Reported balance
After 2026-04-14 transaction · row 1
1 source rowRow 1 · 2026-04-14 · Sale · Disposed 8 · Balance 9,157 F1: Represents shares sold by the Reporting Person on April 14, 2026 for tax purposes. |
| Common StockSEC Table I · non-derivative | IndirectBy: Longnecker Associates Ltd | 0 |
Reported balance
After 2026-04-14 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-04-14 · Sale · Disposed 10 · Balance 0 F1: Represents shares sold by the Reporting Person on April 14, 2026 for tax purposes. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold by the Reporting Person on April 14, 2026 for tax purposes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2026 Filed Apr 15, 2026 22:50 UTC | Genprex, Inc. GNPX · Entity 8441 | SaleCommon Stock | 10 | $1.23 | $12.30 |
DisclosureSEC source: 0001437749-26-012463 · rdgdoc.xml · nonDerivative · entry 2 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By: Longnecker Associates Ltd Disclosed balance after: 0 F1 · shares: Represents shares sold by the Reporting Person on April 14, 2026 for tax purposes. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 22:50 UTC | Genprex, Inc. GNPX · Entity 8441 | SaleCommon Stock | 8 | $1.23 | $9.84 |
DisclosureSEC source: 0001437749-26-012463 · rdgdoc.xml · nonDerivative · entry 1 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,157 F1 · shares: Represents shares sold by the Reporting Person on April 14, 2026 for tax purposes. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 22:32 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038733 · rdgdoc.xml · nonDerivative · entry 1 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,165 F1 · shares: This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025, the "EIP") and vests 100% upon the earlier of (a) August 15, 2026 and (b) the day prior to the Company's next annual meeting of stockholders occurring after the grant date, provided that the recipient continues to serve as a Service Provider (as defined in the Company's EIP) through the applicable vesting date. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. F2 · balance_after: This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-50 reverse stock split of the Company's Common Stock effected as of October 21, 2025 (the "RSS"). Read SEC document |
| December 05, 2024 Filed Dec 6, 2024 22:51 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-036882 · rdgdoc.xml · nonDerivative · entry 1 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,220 F1 · shares: This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests 100% upon the earlier of (a) June 30, 2025 and (b) the day prior to the Company's next annual meeting of stockholders occurring after the grant date, provided that the recipient continues to serve as a Service Provider (as defined in the Company's 2018 Equity Incentive Plan) through the applicable vesting date. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. F2 · balance_after: This total represents the amount of securities beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's common stock effected as of February 2, 2024 (the "RSS"). Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 22:07 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantCommon Stock | 123,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-018941 · rdgdoc.xml · nonDerivative · entry 1 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,795 F1 · shares: This award of Restricted Stock Units ("RSUs") is granted pursuant to the Genprex, Inc. (the "Company") Amended and Restated Outside Director Compensation Policy. One hundred percent (100%) of the RSUs shall vest upon the earlier of (a) the one (1) year anniversary of June 27, 2023 and (b) the day prior to the Company's next annual meeting of stockholders occurring after the grant date, provided that the Outside Director continues to serve as a Service Provider (as defined in the Company's 2018 Equity Incentive Plan) through the applicable vesting date. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:48 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 83,368 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001437749-22-016005 · rdgdoc.xml · derivative · entry 1 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,368 Underlying: Common Stock · 83,368 shares Expires 2032-06-23 F1 · derivative.exercise_price: Equal to the fair market value of a share of common stock on June 23, 2022, the date on which the option grant was made under the Genprex, Inc. Outside Director Compensation Policy. F2 · derivative.exercise_date: One hundred percent (100%) of the Shares subject to the Option shall vest upon the earlier of (a) the one (1) year anniversary of June 23, 2022 and (b) the day prior to the Company's next annual meeting of the Company's stockholders occurring after the grant date, provided that the Optionee continues to serve as a Service Provider (as defined in the Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 23:03 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 32,376 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001437749-21-015721 · rdgdoc.xml · derivative · entry 1 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,376 Underlying: Common Stock · 32,376 shares Expires 2031-06-24 F1 · derivative.exercise_price: Equal to the fair market value of a share of common stock on June 24, 2021, the date on which the option grant was made under the Genprex, Inc. Outside Director Compensation Policy. F2 · derivative.exercise_date: One hundred percent (100%) of the Shares subject to the Option shall vest upon the earlier of (a) the one (1) year anniversary of June 24, 2021 and (b) the day prior to the Company's next annual meeting of the Company's stockholders occurring after the grant date, provided that the Optionee continues to serve as a Service Provider (as defined in the Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 20:41 UTC | Genprex, Inc. GNPX · Entity 8441 | PurchaseCommon Stock | 15,000 | $4.15 | $62,250.00 |
DisclosureSEC source: 0001437749-21-008469 · rdgdoc.xml · nonDerivative · entry 1 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reported is a weighted average price. A total of 15,000 shares were purchased in multiple transactions at prices ranging from $4.1375 per share to $4.16 per share. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 20:46 UTC | Genprex, Inc. GNPX · Entity 8441 | GrantStock Option (right to buy) · Derivative | 42,068 | $0.00 Strike: $3.69 | $0.00 |
DisclosureSEC source: 0001437749-20-015875 · rdgdoc.xml · derivative · entry 1 LONGNECKER BRENT M · CIK 0001218777 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,068 Underlying: Common Stock · 42,068 shares Expires 2030-07-24 F1 · derivative.exercise_price: Equal to the greater of (a) the fair market value of a share of common stock on June 18, 2020, the date on which the option grant was to be made under the Genprex, Inc. Outside Director Compensation Policy and (b) the fair market value of a share of common stock on July 24, 2020, the date on which the option grant was made. F2 · derivative.exercise_date: One hundred percent (100%) of the Shares subject to the Option shall vest upon the earlier of (a) the one (1) year anniversary of June 18, 2020 and (b) the day prior to the Company's next annual meeting of the Company's stockholders occurring after the grant date, provided that the Optionee continues to serve as a Service Provider (as defined in the Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.